Sofosbuvir/Pegylated-interferon Plus Ribavirin With HCV Genotype 4

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This study aims to assess the efficacy and safety of sofosbuvir (SOF) with pegylated interferon (PegINF)/ribavirin (RBV) for chronic HCV GT4 participants
Epistemonikos ID: 29f1489791d1faae9e8a577ccc131d9815d6025b
First added on: May 07, 2024